Combination Immunotherapy May Further Increase Melanoma Survival Length

Elisa Becze, BA, ELS, Editor
Voice

Description

Using two agents that target two different receptors more than doubles length of survival for advanced melanoma than a single agent alone, researchers reported at the 2021 American Society of Clinical Oncology annual meeting.

View Article @ voice.ons.org

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles